The final goal of Genome Center is to apply adequate therapies with more effect and less adverse effect to each cancer patient. To achieve as to say order made cancer therapy we take the single nucleotide polymorphism (SNP) analysis approach mainly to predict the adverse effect and microarray analysis approach which can predict the response by various therapies. And also to screen the SNPs or expressed genes correspond to the phenotype from huge number of data, we are constructing an integrated cancer genome database.
